Instruments represent 75% of product sales and bioprocess analysis accounts for 69% within the application segment in 2026. The real-time bioprocess raman analyzer market is estimated at USD 23.2 million in 2026, is projected to reach USD 36.9 million by 2036 and is forecast to post a 4.8% CAGR between 2026 and 2036.